| Date | State | Bill No. | Title | Outcome |
|---|
| Date | No. | Title | Outcome |
|---|
| Date | Title | Politician |
|---|---|---|
| April 14, 2021 | Timely Reauthorization of Necessary Stem-Cell Programs Lends Access to Needed Therapies Act of 2021 | Rep. Gus Bilirakis |
| Oct. 21, 2019 | Matsui, Bilirakis, Pingree Introduce Life-Saving Stem Cell Therapeutic and Research Reauthorization Bill | Rep. Gus Bilirakis |
| Sept. 17, 2018 | Letter to Dr. Scott Gottlieb, Commissioner of the Food and Drug Administration - Abraham: HHS Right to Cancel Fetal Tissue Contract | Rep. Daniel Webster |
| Sept. 17, 2018 | Letter to Dr. Scott Gottlieb, Commissioner of the Food and Drug Administration - Abraham: HHS Right to Cancel Fetal Tissue Contract | Rep. Gus Bilirakis |
| May 22, 2017 | Letter to Donald J. Trump, President of the United States of America - Appointment of a Pro-life NIH Director | Rep. Daniel Webster |
| Date | Title | Politician |
|---|---|---|
| April 14, 2021 | Timely Reauthorization of Necessary Stem-Cell Programs Lends Access to Needed Therapies Act of 2021 | Rep. Gus Bilirakis |
| Oct. 21, 2019 | Matsui, Bilirakis, Pingree Introduce Life-Saving Stem Cell Therapeutic and Research Reauthorization Bill | Rep. Gus Bilirakis |
| Sept. 17, 2018 | Letter to Dr. Scott Gottlieb, Commissioner of the Food and Drug Administration - Abraham: HHS Right to Cancel Fetal Tissue Contract | Rep. Daniel Webster |
| Sept. 17, 2018 | Letter to Dr. Scott Gottlieb, Commissioner of the Food and Drug Administration - Abraham: HHS Right to Cancel Fetal Tissue Contract | Rep. Gus Bilirakis |
| May 22, 2017 | Letter to Donald J. Trump, President of the United States of America - Appointment of a Pro-life NIH Director | Rep. Daniel Webster |
| Year(s) | Special Interest Group |
|---|
| Election Date | State | Title | Outcome |
|---|